ELOXX PHARMACEUTICALS, INC. Development Stage Entities, Stock Issued, Value, Issued for Cash (Deprecated 2015-01-31)
ELOXX PHARMACEUTICALS, INC. (ELOX) reported Development Stage Entities, Stock Issued, Value, Issued for Cash (Deprecated 2015-01-31) of $100.57 thousand for the 9-month period ending 2013-03-31, per its 10-Q filed 2013-05-15.
Discontinued › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement
us-gaap:StockIssuedDuringPeriodValueIssuedForCash · last filed 2013-05-15
- 2013-03-31: Development Stage Entities, Stock Issued, Value, Issued for Cash (Deprecated 2015-01-31) 9 month $100.57K.
| Period end | Development Stage Entities, Stock Issued, Value, Issued for Cash (Deprecated 2015-01-31) 9 month |
|---|---|
| 2013-03-31 | $100.57K 10-Q · filed 2013-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Tevogen Inc. (TVGN) | United States | $0.049B |